The journey of developing new medicines brings together different
organisations and people who are driven by the desire to make a real
impact on people's lives. AbbVie collaborates extensively with
researchers and scientists in universities, hospitals and start-up
businesses, helping to search for science which could, in the future,
have a remarkable impact on patient lives.
As medicines are developed, many patients take part in extensive
clinical trials. The medicines are also reviewed by the Therapeutic
Goods Administration to assess safety and efficacy, and to confirm
quality. Following this, an independent body then assesses the value
of innovative medicines and, through the Pharmaceutical Benefits
Scheme, the government then funds those it determines to have the
greatest benefit to Australians. This gives affordable and universal
access to new medicines.
We've highlighted the processes of the medicines ecosystem in this
video, so you can see just how critical innovation is for uncovering
medicines of the future.
Find out more